NCT03295188View on ClinicalTrials.gov

Effects of Plasmalogen on Obese Subjects

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

August 22, 2018

Study Completion Date

August 22, 2018

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Plasmalogen

Treatment group takes two 0.5 mg plasmalogen capsules per day for 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo Group takes two placebo capsules per day for 12 weeks.

Trial Locations (1)

8120025

BOOCS Clinic Fukuoka, Fukuoka

All Listed Sponsors
lead

Japanese Plasmalogen Society

OTHER

NCT03295188 - Effects of Plasmalogen on Obese Subjects | Biotech Hunter | Biotech Hunter